Although lipid profile is a crucial standard for assessing CVD risk in SLE patients, glucose and insulin levels are essential for assessing IR, a clinical state characterized by reduced insulin efficacy associated with increased insulin release and elevated blood concentration in an attempt to obtain an effective response to circulating glucose levels [23]. The gene discussed is INS; the disease is systemic lupus erythematosus.